What is HIV PrEP?
PrEP stands for “pre-exposure prophylaxis.” It is a medication that prevents infection from the human immunodeficiency virus (HIV) that is transmitted in semen, vaginal fluids, blood and breast milk.
There are several options approved for PrEP:
- Truvada (oral, approved in 2012)
- Descovy (oral, approved in 2019)
- Apretude (injectable, approved in 2021)
- Yeztugo (injectable, a newer long-acting option)
Oral PrEP is taken daily. Taken consistently, it reduces the chance of getting HIV from sex by up to 99%. There's less data on the effectiveness of reducing HIV from injection drug use, but daily oral PrEP is thought to reduce that risk by at least 74%.
Injectable PrEP is given as a shot into the muscle by your care team. Some people start with an optional one-month oral lead-in to check how they tolerate the medication. After the first injection, a second follows one month later, then injections continue on a set schedule every two months. Because injectable options are longer-acting, they can be a great fit if remembering a daily pill is a challenge.
PrEP will NOT protect against other sexually transmitted infections (STIs) including chlamydia, gonorrhea, syphilis and herpes. For this reason, condoms and regular STI screenings or checkups are still recommended.